Product Liability 101 for Medical Device Companies

FDA clearance gets your device to market. Product liability insurance is what protects you once it’s there — and the two are not as aligned as most founders assume.

For most medtech founders, the path to commercialization is defined by milestones: prototype, IDE, 510(k) clearance or PMA approval, first commercial sale. Insurance tends to be treated as an administrative checkbox somewhere in that sequence — something to sort out before a distributor or hospital system asks for a certificate.

That’s the wrong frame. For medical device companies, product liability insurance isn’t paperwork. It’s the financial structure that determines whether your company survives its first serious adverse event. Here’s what you need to understand before your first unit ships.

What Product Liability Insurance Actually Covers for Device Makers

Medical device product liability insurance protects manufacturers against claims arising from device malfunctions, adverse events, or design defects. In practice, it responds when a patient, healthcare provider, or other third party alleges that your device caused bodily injury or property damage — and the insurer steps in to cover legal defense costs, settlements, and judgments up to your policy limits.

A standard product liability policy for a device manufacturer typically covers:

• Bodily injury or property damage caused by a device you manufactured, distributed, or sold
• Legal defense costs, including attorney fees, expert witnesses, and court costs
• Settlements and judgments up to the policy limit
• Claims arising from design defects, manufacturing defects, or failure to warn (inadequate labeling or instructions for use)

What it does not automatically cover — and what trips up most early-stage companies — are product recall expenses, crisis management costs, regulatory defense, and revenue losses from a market withdrawal. Medical device insurance usually starts with product liability coverage, but it often won’t cover recall expenses, replacement logistics, crisis management, or lost revenue unless you buy standalone recall coverage.

FDA Device Classification and What It Means for Your Coverage

Every medical device sold in the United States falls into one of three FDA risk categories: Class I (low risk), Class II (moderate risk), or Class III (high risk). The classification dictates how much regulatory scrutiny a device faces before reaching the market. It also directly shapes your insurance program.

Class I devices — bandages, examination gloves, manual surgical instruments — present minimal patient risk and are subject only to general controls. Class I devices have the most affordable premiums and the widest carrier availability. For a startup in this category, coverage is more accessible and limits can be calibrated to early-stage revenue.

Class II devices — diagnostic imaging equipment, infusion pumps, continuous glucose monitors — present moderate risk and typically require 510(k) clearance demonstrating substantial equivalence to a predicate device. These devices involve more complex patient interaction, and insurers price that risk accordingly. Coverage limits in the $2–$10 million range are standard for growth-stage companies in this class, though distributor and hospital system contracts may require higher.

Class III devices — implantable cardiac devices, neurostimulators, ventricular assist devices — carry the highest potential risk because they are often life-sustaining, life-supporting, or critical to patient health, requiring the most stringent regulatory pathway: Premarket Approval (PMA). Insurers treat these accordingly. Carrier availability narrows significantly, underwriting scrutiny increases, and coverage limits of $10 million or more are common requirements for hospital procurement contracts. For Class III manufacturers, the insurance program requires specialist brokers with life sciences expertise — standard commercial lines carriers frequently won’t write this risk at all.

The core principle: as the risk class rises, so does the complexity and cost of the coverage you need. Your insurance program should mirror your FDA classification, not your revenue stage.

The Moment of First Commercial Sale — and Why It Changes Everything

Before your device is on the market, your liability exposure is primarily clinical and regulatory: trial-related adverse events, IP disputes, investor representations. These are real risks, but they’re generally manageable within a pre-commercial insurance structure.

The moment your first unit ships commercially, the liability landscape shifts permanently. Every device that leaves your facility is a potential claim. Every patient who uses it is a potential plaintiff. Every distributor in your supply chain becomes a link in a product liability chain that traces back to you as the manufacturer.

Manufacturers bear primary responsibility for product design, testing, and production and are almost always named in product liability claims — being one step removed from the end user does not remove legal exposure, and product liability claims can target anyone in the chain of distribution.

This means your policy must reflect the commercial reality of your device — the markets it reaches, the geographies it’s sold in, the clinical environments it’s used in, and the patient populations it affects — before that first shipment goes out the door. Updating coverage retroactively after a claim surfaces is not an option.

The 4 Most Common Gaps in Medtech Product Liability Coverage

Gap 1: No standalone product recall coverage. A product liability policy responds to claims. It does not pay for the operational costs of a recall — logistics, replacement inventory, field corrections, patient notification, crisis communications, or regulatory response. For a company with devices in active clinical use, a recall without dedicated recall insurance is a cash crisis layered on top of a reputational crisis.

Gap 2: Software and SaMD excluded or underaddressed. If your device includes software — embedded algorithms, companion apps, AI-assisted diagnostics — your product liability policy may not fully cover claims arising from software performance failures. The right program for device companies increasingly combines product liability with errors and omissions or tech E&O coverage when software or performance claims are involved. Software as a Medical Device (SaMD) classifications from the FDA are still evolving, and many standard product liability policies haven’t kept pace.

Gap 3: Geographic scope doesn’t match actual sales. A policy written for domestic U.S. sales may exclude claims arising from devices sold or used internationally. For companies selling through EU distributors, pursuing CE marking, or supplying devices to international hospitals, this gap can be substantial. Confirm your policy’s territorial scope matches where your devices actually go.

Gap 4: Coverage limits set at funding stage, not commercial stage. Many startups set their product liability limits based on what was required to close a Series A or sign an initial distributor agreement. Those limits may have been appropriate at the time — and be woefully inadequate by the time the company has devices in widespread clinical use. As your installed base grows, your limits need to grow with it.

A Real-World Scenario: What a Product Liability Claim Looks Like for a Monitoring Device Manufacturer

A growth-stage company has received 510(k) clearance for a continuous patient monitoring device used in post-surgical recovery. Eighteen months after commercial launch, an adverse event report is filed: a patient at a hospital system client experienced a delayed deterioration event, and the family’s legal team alleges the monitoring device failed to generate an alert when the patient’s vitals fell outside normal parameters.

The manufacturer is named in the lawsuit alongside the hospital. The family’s attorneys allege a software defect in the alerting algorithm. Legal defense begins immediately — expert witnesses, software audit, depositions. Eighteen months in, the case settles.

A well-structured product liability policy with adequate limits responds to legal defense costs from day one and covers the settlement. The company survives the claim. A policy with inadequate limits, a software exclusion, or a lapsed renewal at the wrong moment would have produced a very different outcome.

The device passed FDA clearance. The device had been in clinical use for over a year without incident. The claim came anyway — because that’s the nature of product liability in a clinical environment.

What to Do Now

If you’re approaching your first commercial launch, or already in market and haven’t reviewed your coverage in the past 12 months, these are the questions your broker should be answering:

• Does your current policy limit reflect your installed base and your largest hospital contract’s indemnification requirements?
• Is software performance covered, or does your policy exclude it?
• Do you have standalone product recall coverage?
• Does your territorial scope match your actual distribution?
• Is your policy written on an occurrence or claims-made basis — and if claims-made, what does your tail coverage look like?

Medical device insurance is not about eliminating risk. It’s about ensuring one incident does not end the business.

This article is for educational purposes only and does not constitute legal or insurance advice. Consult any of our licensed insurance agents to review your specific coverage needs.